Table 3.
Baseline clinical variables associated with stroke events during the trial in univariable (left) and multivariable models (right)
| Variable | Hazard Ratio (95% Confidence Interval) | P Value | Hazard Ratio (95% Confidence Interval) | P Value |
|---|---|---|---|---|
| Sex, women/men | 2.11 (1.31 to 3.40) | 0.002 | 2.15 (1.34 to 3.45) | 0.002 |
| Diabetes, yes/no | 2.09 (1.26 to 3.47) | 0.004 | 2.08 (1.25 to 3.45) | 0.005 |
| Stroke, yes/no | 1.98 (1.03 to 3.78) | 0.04 | 2.02 (1.06 to 3.85) | 0.03 |
| SBP, per 10 mm Hg | 1.18 (1.07 to 1.30) | 0.001 | 1.18 (1.07 to 1.30) | <0.001 |
| Dialysis vintage duration, per mo | 0.87 (0.54 to 1.41) | 0.58 | ||
| Age, per 5 yr | 1.08 (0.98 to 1.19) | 0.10 | ||
| AF, yes/no | 0.78 (0.28 to 2.18) | 0.63 | ||
| Vascular access, graft/fistula/catheter | 0.78 (0.48 to 1.25) | 0.30 | ||
| Treatment, proactive/reactive | 0.89 (0.48 to 1.44) | 0.64 |
SBP, systolic BP; AF, atrial fibrillation.